Parallax Volatility Advisers
DCPH

Parallax Volatility Advisers’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Parallax Volatility Advisers’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,302
Closed -$30K – 4583
2017
Q4 		$30K Buy
+1,302
New +$25.5K ﹤0.01% 3499

Other funds holding DCPH

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Parallax Volatility Advisers's DCPH Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2018, closing a stake of 1,302 shares — an estimated $30K sold.

Parallax Volatility Advisers first reported a position in DCPH in Q4 2017 and held it in 1 quarter. The position peaked at $30K in Q4 2017. 55 funds tracked by Wall St. Rank hold DCPH as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,302 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2018, an estimated $30K.
  • Parallax Volatility Advisers first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $30K in Q4 2017.
  • 55 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.